Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy
Related Posts
Lim Chang C, Chung PJ, Ngan H, Porras-Javier L, Vangala S, Correa-Mendoza L, Calderon K, Thompson LR, Molina D, Aceves I, Torres F, Dudovitz R.[...]
Limothai U, Srisawat N, Haake DA. Early Diagnosis and Treatment of Leptospirosis: Optimizing Clinical Outcomes. J Infect. 2026 Jan 9:106675. doi: 10.1016/j.jinf.2025.106675. Epub ahead of[...]
Nguyen T, Chang CE, Tao R, Liu K, Zhang ZF, Hashibe M. Risk of incident cardiovascular disease events among older Asian, Native Hawaiian, and Pacific[...]